ARCHIVES

Centers, Cancer Control Would Get Larger Shares of NCI Increase In House Bill; Grant Total Drops

This article is from The Cancer Letter archive.

Vol. 13 No. 35 | August 28, 1987

Download PDF Visit The Full Archive

Related Articles

Nancy Brinker Resigns As CEO of Komen

August 10, 2012

Endostatin Enters Phase II Trial For Neuroendocrine Tumors.

December 14, 2001

Response From Center Representatives In L.A. To NCI Questions Is “Frusterating,” DeVita Says

April 13, 1984

MSKCC Asked To Repay $638,371 To NIH

December 13, 1985

ASCO Picks Charles Balch To Succeed John Durant as Executive Vice President.

January 7, 2000

US Oncology Begins Phase III Trial Of Bcl-2 Antisense With Chemo For Melanoma.

July 28, 2000